4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor.

作者: Kristian Tveten , Øystein L. Holla , Trine Ranheim , Knut E. Berge , Trond P. Leren

DOI: 10.1111/J.1742-4658.2007.05735.X

关键词:

摘要: Familial hypercholesterolemia is an autosomal dominant disease caused by mutations in the gene encoding low-density lipoprotein receptor. To date, more than 900 different have been described. Transport-defective (class 2) causing partial or complete retention of receptor endoplasmic reticulum are predominant class mutations. In a cell culture system (Chinese hamster ovary cells), we show that chemical chaperones able to mediate rescue transport-defective mutant (G544V), and ability obtain mutation dependent. particular, low molecular mass fatty acid derivative 4-phenylbutyrate mediated marked increase transport G544V-mutant plasma membrane. Thirty per cent was escape from reach surface. The rescued had reduced stability, but found be as efficient wild-type binding internalizing lipoprotein. addition 4-phenylbutyrate, also studied 3-phenylpropionate 5-phenylvalerate, compared their effect on with overall expression histone deacetylase inhibitor activity. No correlation found. Our results indicate these agents not solely induce proteins involved intracellular transport, rather could due direct chaperone These data suggest possible it might feasible develop pharmacologic treat familial patients class 2

参考文章(48)
N E Maestri, S W Brusilow, UREA CYCLE DISORDERS: DIAGNOSIS, PATHOPHYSIOLOGY, AND THERAPY Advances in Pediatrics. ,vol. 43, pp. 127- 170 ,(1996)
E. Papp, P. Csermely, Chemical Chaperones: Mechanisms of Action and Potential Use Handbook of experimental pharmacology. ,vol. 172, pp. 405- 416 ,(2006) , 10.1007/3-540-29717-0_16
R. R. Williams, I. Hamilton-Craig, G. M. Kostner, R. A. Hegele, M. R. Hayden, S. N. Pimstone, O. Faergeman, H. Schuster, E. Steinhagen-Thiessen, U. Beisiegel, C. Keller, A. E. Czeizel, E. Leitersdore, J. C. Kastelein, J. J. P. Defesche, L. Ose, T. P. Leren, H. C. Seftel, F. J. Raal, A. D. Marais, M. Eriksson, U. Keller, A. R. Miserez, T. Jeck, D. J. Betterridge, S. E. Humphries, I. N. M. Day, P. O. Kwiterovich, R. S. Lees, E. Stein, R. Illingworth, J. Kane, V. Boulyjenkov, MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths Genetic Approaches to Noncommunicable Diseases. pp. 35- 45 ,(1996) , 10.1007/978-3-642-61028-8_5
U. Beisiegel, W.J. Schneider, J.L. Goldstein, R.G. Anderson, M.S. Brown, Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. Journal of Biological Chemistry. ,vol. 256, pp. 11923- 11931 ,(1981) , 10.1016/S0021-9258(19)68494-2
Lee R. Choo-Kang, Pamela L. Zeitlin, Induction of HSP70 promotes ΔF508 CFTR trafficking American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 281, ,(2001) , 10.1152/AJPLUNG.2001.281.1.L58
Hyesung Jeon, Wuyi Meng, Junichi Takagi, Michael J. Eck, Timothy A. Springer, Stephen C. Blacklow, Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nature Structural & Molecular Biology. ,vol. 8, pp. 499- 504 ,(2001) , 10.1038/88556
Birgit Meusser, Christian Hirsch, Ernst Jarosch, Thomas Sommer, ERAD: the long road to destruction Nature Cell Biology. ,vol. 7, pp. 766- 772 ,(2005) , 10.1038/NCB0805-766
Alexandra Spenger, Wolfgang Ernst, J. Patrick Condreay, Thomas A. Kost, Reingard Grabherr, Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells Protein Expression and Purification. ,vol. 38, pp. 17- 23 ,(2004) , 10.1016/J.PEP.2004.08.001
Helge Tolleshaug, Joseph L. Goldstein, Wolfgang J. Schneider, Michael S. Brown, Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia Cell. ,vol. 30, pp. 715- 724 ,(1982) , 10.1016/0092-8674(82)90276-8